Insights with Goldman Sachs Part 1: Future predictions
Biopharma has been on a roller coaster for the past few years. Now, a more predictable global ecosystem, incredible innovation in science and technology, and a booming investment environment are opening-up exciting opportunities for large pharma and biotechs alike. Tune in for more future predictions from our panel discussion including Jerry Lee, Partner of Global Healthcare Investment Banking Group at Goldman Sachs, and Lyla Bibi, Managing Director and Head of Americas Healthcare Equity Capital Markets at Goldman Sachs.
Disclaimer: The views and opinions that the panelists express are their own and are for informational purposes only. They do not constitute a recommendation by Goldman Sachs Asset Management for you to take any action. This video includes the perspectives of Amy McKee, our previous Chief Medical Officer & Global Head, Oncology Center of Excellence. Amy left Parexel in August 2024.
Related Insights
Video
Insights with Goldman Sachs Part 2: How pharma is using M&A for growth and innovation
Jan 26, 2024
Video
Insights with Goldman Sachs Part 3: Regulatory dynamics and research trends
Jan 26, 2024
Video
Insights with Goldman Sachs Part 4: The impact of the Inflation Reduction Act
Jan 26, 2024
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Video
Insights with Goldman Sachs Part 6: Generating investor interest
Jan 26, 2024